Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XalMeds is a Philippine-based health technology startup that operates an FDA-licensed online pharmacy and telemedicine platform. Founded by Orlando R. Palompon, a former pharmaceutical executive, the company focuses on providing affordable access to maintenance medications for chronic conditions like diabetes, hypertension, and cardiovascular diseases. XalMeds utilizes a subscription-based model and a '3-in-1' vision that integrates online pharmacy services, telemedicine consultations, and electronic health records. The company specifically targets underserved populations in rural and geographically isolated areas (GIDAs) to improve healthcare equity and treatment compliance. Through its social impact arm, XhareMeds, the company also supports medical missions and provides free health screenings to disadvantaged communities. XalMeds is a graduate of the Founder Institute accelerator and has been recognized as a leading innovation in the Filipino healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XalMeds.